Scott J. Cotler

Scott J. Cotler

Auto-generated profile, based on publicly available information

Scott J. Cotler

The Program for Experimental & Theoretical Modeling,Division of Hepatology,Department of Medicine,Stritch School of Medicine,Loyola University Chicago,Maywood,IL

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2016 in Canadian Journal of Gastroenterology and Hepatology
Verified
Journal Article
Open access
PDF file
LDLan Dam
Lan Dam
ACAnita Cheng
Anita Cheng
PTPhuong Tran
Phuong Tran
SWShirley S. Wong
Shirley S. Wong
RHRonald Hershow
Ronald Hershow
SCScott J. Cotler
Scott J. Cotler
Stigma regarding viral hepatitis and liver disease has psychological and social consequences including causing negative self-image, disrupting relationships, and providing a barrier to prevention, testing, and treatment. The aim of this study was to characterize and compare HBV knowledge and stigma in Vietnamese in Ho Chi Minh City and Chicago and to begin to evaluate the cultural context of HBV stigma.Methods. A written survey including knowledge questions and a validated HBV stigma questionnaire was distributed to Vietnamese in Ho Chi Minh City and Chicago. 842 surveys from Ho Chi Minh City and 170 from Chicago were analyzed.Results. Vietnamese living in Chicago had better understanding of HBV transmission and that HBV can cause chronic infection and liver cancer. Vietnamese in Chicago had higher stigma scores on a broad range of items including guilt and shame about HBV and were more likely to feel that persons with HBV can bring harm to others and should be isolated.Conclusions. Vietnamese in Ho Chi Minh City and Chicago have knowledge deficits about HBV, particularly regarding modes of transmission. Persons in Ho Chi Minh City expressed lower levels of HBV stigma than Vietnamese living in Chicago, likely reflecting changing cultural attitudes in Vietnam. Culturally appropriate educational initiatives are needed to address the problem of HBV stigma.

1 April 2019 in Experimental and Clinical Transplantation
Verified
Journal Article
Closed access
MMMiguel Malespin
Miguel Malespin
CMChristopher M. Moore
Christopher M. Moore
AFAndre Fialho
Andre Fialho
WMWamderley José de Melo
Wamderley José de Melo
TBTamara Benyashvili
Tamara Benyashvili
ALAmy D. Lu
Amy D. Lu
Ascites represents an important event in the natural history of cirrhosis, portending increased 1-year mortality. Umbilical herniation with rupture is an uncommon complication of large-volume ascites that is associated with significant morbidity and mortality. The aim of this study was to describe predictors of outcomes in patients undergoing emergent repair for spontaneous umbilical hernia rupture. We report a case series of 10 patients with decompensated cirrhosis (mean age 66 ± 9 years, mean Model for End-Stage Liver Disease score of 21 ± 7) who presented with a ruptured umbilical hernia and had emergent repair. Thirty percent (3/10) of patients died or required liver transplant. Factors associated with death or transplant included the development of bacterial peritonitis (P = .03) and the presurgical 30-day Mayo Clinic Postoperative Mortality Risk in Patient with Cirrhosis Score (P = .03). Emergent repair after umbilical hernia rupture in patients with decompensated cirrhosis carries a poor prognosis with 30% of patients developing poor postsurgical outcomes.

1 January 2012 in Diagnostic and Interventional Radiology
Verified
Journal Article
Closed access
FYFelix Y. Yap
Felix Y. Yap
JBJamie L. Berkes
Jamie L. Berkes
MKM. Grace Knuttinen
M. Grace Knuttinen
NWNatasha M. Walzer
Natasha M. Walzer
SCScott J. Cotler
Scott J. Cotler
RGRon Charles Gaba
Ron Charles Gaba
Diagnostic and Interventional Radiology

1 July 2008 in Disease-a-Month
Verified
Journal Article
Closed access
EKEric R. Kallwitz
Eric R. Kallwitz
SCScott J. Cotler
Scott J. Cotler


31 May 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
ETEric Tatara
Eric Tatara
AGAlexander Gutfraind
Alexander Gutfraind
NCNicholson T. Collier
Nicholson T. Collier
DEDesarae Echevarria
Desarae Echevarria
SCScott J. Cotler
Scott J. Cotler
BBBasmattee Boodram
Basmattee Boodram
Hepatitis C virus (HCV) infection is a leading cause of chronic liver disease and mortality worldwide. Direct-acting antiviral (DAA) therapy leads to high cure rates. However, persons who inject drugs (PWID) are at risk for reinfection after cure and may require multiple DAA treatments to reach the World Health Organization’s (WHO) goal of HCV elimination by 2030. Using an agent-based model (ABM) that accounts for the complex interplay of demographic factors, risk behaviors, social networks, and geographic location for HCV transmission among PWID, we examined the combination(s) of DAA enrollment (2.5%, 5%, 7.5%, 10%), adherence (60%, 70%, 80%, 90%) and frequency of DAA treatment courses needed to achieve the WHO’s goal of reducing incident chronic infections by 90% by 2030 among a large population of PWID from Chicago, IL and surrounding suburbs. We also estimated the economic DAA costs associated with each scenario. Our results indicate that a DAA treatment rate of >7.5% per year with 90% adherence results in 75% of enrolled PWID requiring only a single DAA course; however19% would require 2 courses, 5%, 3 courses and <2%, 4 courses), with an overall DAA cost of $325 million to achieve the WHO goal in metropolitan Chicago. We estimate a 28% increase in the overall DAA cost under low adherence (70%) compared to high adherence (90%). Our modeling results have important public health implications for HCV elimination among U.S. PWID. Using a range of feasible treatment enrollment and adherence rates, we report robust findings supporting the need to address re-exposure and reinfection among PWID to reduce HCV incidence.